Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-29
2011-03-29
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S121000
Reexamination Certificate
active
07915284
ABSTRACT:
The present invention is related to a compound of formula (I)wherein R1, R2, R3and R4are as defined herein, or an addition salt of an acid thereof, the pharmaceutical composition and preparation thereof, and the therapeutic use thereof in the treatment or the prevention of diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
REFERENCES:
patent: 2001035664 (2001-02-01), None
patent: WO 01/74813 (2001-10-01), None
patent: WO 2004/026867 (2004-04-01), None
patent: WO 2004/072050 (2004-08-01), None
patent: WO 2005/086808 (2005-09-01), None
Enguehard, C., et. al., (Hetero)Arylation of 6-Halogenoimidazo [1,2-a]Pyridines Differently Substituted at C(2): Influence of the 2-Substituent on the Suzuki Cross-Coupling Reaction, Helvetica Chimica Acta, vol. 84, (2001).
Wang, Z., et. al., Structute and Function of Nurr1 Identifies a Class of Ligand-Independent Nuclear Receptors, Nature vol. 423, 555-560, (2003).
Almario Garcia Antonio
Lardenois Patrick
Olivier Anne
Lin Jiang
Rahmani Niloofar
Sanofi-Aventis
Seaman D. Margaret
LandOfFree
2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2735803